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The aim of this study is to report complications of transcatheter ASD clo-
sure using the Amplatzer Septal Occluder (ASO) (St Jude Medical). 
From December 1999 to October 2013 (April 2014), 760 patients under-
went ASD closure with the ASO. Closure was mostly performed under gen-
eral anaesthesia and transoesophageal echocardiography control. Choice of the
device diameter was established after balloon sizing and measurement of the
stretched diameter. 
Mean age of the patients was 31.9±22 years (0.5 month – 84 years). The
stretched diameter was 22.5±6.6 mm (5-40mm) and device dimension
22±6.7mm (4-40mm). Duration of the procedure was 41±15 minutes (10-120
minutes) and fluoroscopic time 7.63±6.65 minutes (1-92 minutes). Dose of
radiation was 18.7±22 Gy.cm2 (median 12 Gy.cm2). 
Implantation succeeded in 96.3% of pts and failure was mainly related to
deficient rim. No device related death was noticed. Embolization occurred in
4 pts (0.5%): 1 in the aorta, 1 in the left ventricle, and 2 in the pulmonary
artery. All but one underwent surgical extraction and ASD closure. The
patient with aortic embolization had percutaneous device extraction and
underwent subsequently successful implantation with a larger device. No
patient required blood transfusion for any groin hematoma. One patient
without aortic rim had hemopericardium one month after implantation; this
was corrected by drainage with no recurrence and ASD full occlusion was
noticed on colour Doppler control. No late complication was observed. The
rate of full occlusion on Doppler control is more than 90%, and the remain-
ings have trivial shunt.
Transcatheter ASD occlusion with the Amplatzer Septal Occluder is a safe
and effective procedure. The rate of immediate complication is very low and
need for immediate surgery following the implantation is rare (<1%). No
device related late complications were reported up to 15 years after implanta-
tion. The risk of aortic perforation in absence of anterior rim (observed in
about 20% of pts) is trivial and not a real limitation in clinical practice.
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Objective: To describe the early and midterm outcome after atrio-ventri-
cular valve (AVV) procedure in patients with univentricular hearts (UVH) and
to identify risk factors for AVV reoperation and death. 
Methods: Retrospective review of patients undergoing procedure for AVV
regurgitation at any phase of univentricular palliation from 1998-2013. Patient
and procedure related variables were analyzed.
Results: 28 consecutive patients underwent 34 procedures for moderate+
AVV regurgitation at a median age of 3.7 years. 29% of patients had a
common, 25% had dominant left, 14% had dominant right AVV and 32% two
AVV. All patients benefited from valve repair at first procedure without early
mortality. At hospital discharge patients preserved their ventricular function
(FS <30%: preop 17% vs. postop 21%, NS) and only 14% had moderate+
residual regurgitation. Dominant left AVV and postoperative moderate+
regurgitation were univariate risk factors for death and transplantation.
Younger age, need for repair before superior cavo-pulmonary shunt and
significant residual regurgitation were univariate risk factors for AVV reopera-
tion. Freedom from death and transplantation was 84% (CI 95%±0.14) at 5
and 10 years. Survival free from AVV reoperation was 77% (CI 95%±0.18)
at 5 years and 66% at 10 years (CI 95±0.25). At last visit, 91% of survivors
were in class NYHA 1-2 without ventricular dysfunction and with mild or less
AVV regurgitation.
Conclusion: Patients with UVH and moderate+ atrio-ventricular valve
regurgitation can profit from AVV repair without deterioration of their ven-
tricular function but remain at increased risk for death and AVV reoperation.
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Aim: to assess the impact of different scanning protocols on radiation dose
and image quality for pediatric coronary computed tomography.
Materials and Methods: 100 children underwent coronary computed
tomography after arterial switch operation from November 2012 to March
2014. Scans were done using two different scanner models without difference
in scanning and image reconstruction parameters: Lightspeed VCT and Dis-
covery HD750, 64-slice from GE Healthcare. Two consecutive changes in
scanning protocols were performed: 1) the use of adaptive statistical iterative
reconstruction (ASIR) instead of filtered back projection (FBP) for image
reconstruction; 2) the optimization of scan acquisition parameters (current and
tube voltage reduction). Premedication (beta-blocker) was used for all children
to obtain heart rate < 80 BPM. Effective dose (ED) was calculated with the
dose-length product method with a conversion factor adjusted for patient age.
Image quality was evaluated by the referent physician. Scans were classified
as « excellent », « good » or « with significant artifacts ». 
Results: Patients were divided in three age groups: 0-4, 5-7 and 8-18
years. After adjustment for scan settings, median ED decreased by 28% (3.9
mSv, IQR 2.8-4.2), 40% (0.9 mSv, IQR 0.6-2.6) and 65% (0.7 mSv, IQR 0.5-
0.9) for 0-4, 5-7 and 8-18 years age groups (p< 0.05), respectively. The pro-
spective protocol (PULSE) was used in 40% of children. The reduction in
radiation dose was not associated with reduction in diagnostic image quality. 
Conclusions: Coronary CT can be obtained at very low radiation doses in
pediatric patients using ASIR and prospective ECG-triggered acquisition with
optimized scan parameters.
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Objectives: This study was design to assess the influence of extracardiac
or chromosomal anomalies on parental decision of termination of pregnancy
and on survival rates in newborns with prenatally diagnosed congenital heart
diseases.
Methods and results: 2057 consecutive foetuses with congenital heart
disease diagnosed from January 2002 to December 2011 were included: 1258
(61%) in-born neonates and 799 (39%) terminations of pregnancy (TOP). The
overall prevalence of major extracardiac or chromosomal anomalies was
18,6%. Of the 1258 newborns, 121 had a major associated anomaly but only
55 were identified before birth. Prenatally identified associated anomalies
were significantly lower in the newborn group in comparison with the TOP
group (4% vs 31%, p<0,0001). They were also lower in the surviving group
at one year of follow up (7,5% vs 20,7%, p<0,0001). A 4-fold increase of
death rate was observed if an associated anomaly was identified (IC95%[2,5-
